Last updated: March 23, 2023
Sponsor: Nanyang Technological University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Diabetic Foot Ulcers
Diabetic Neuropathy
Diabetic Vitreous Hemorrhage
Treatment
N/AClinical Study ID
NCT05535842
NanyangTU_GLOW
Ages > 21 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosed with type 2 diabetes and attending Tan Tock Seng Hospital (TTSH) DiabetesClinic OR caring for a person with type 2 diabetes
- 21 years old or above
- Able to speak and read English
- Singapore nationality or permanent resident or foreign domestic worker (for carers)
- Own a personal mobile device which can download study mobile app
- Access to the internet
Exclusion
Exclusion Criteria:
- Are unable to consent;
- Are pregnant (for patients)
- Received formal training in medicine or allied health services
Study Design
Total Participants: 224
Study Start date:
November 28, 2022
Estimated Completion Date:
September 30, 2023
Study Description
Connect with a study center
Nanyang Technological University, Center for Population Health Sciences, Lee Kong Chian School of Medicine
Singapore, 308232
SingaporeSite Not Available
Tan Tock Seng Hospital
Singapore, 308433
SingaporeActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.